Abstract Seven new 4-hydroxybenzyl-substituted amino acid derivatives (1À 7), together with 11 known compounds, were isolated from an aqueous extract of the rhizomes of Gastrodia elata Blume. Their structures were determined by spectroscopic and chemical methods. Compounds 1À 3 are pyroglutamate derivatives containing 4-hydroxybenzyl units at the N atom and 4 À7 are the first examples of natural products with the 4-hydroxybenzyl unit linked via a thioether bond to 2-hydroxy-3-mercaptopropanoic acid (4À 6) and 2-hydroxy-4-mercaptobutanoic acid (7), which would be biogenetically derived from cysteine and homocysteine, respectively. The structures of 1 and 2 were verified by synthesis, while the absolute configurations of 4, 5 and 7 were assigned using Mosher's method based on the MPA determination rule of Δδ RS values. The known compound 4-(hydroxymethyl)-5-nitrobenzene-1,2-diol (8) exhibited activity against Fe 2þ -cysteine induced rat liver microsomal lipid peroxidation with IC 50 values of 9.99 Â 10 À 6 mol/L.
Introduction
Gastrodia elata Blume is a holomycotrophic perennial plant of the Orchidaceae family, and is widely cultivated in several provinces of China to meet the demands of pharmaceutical and food industries 1 . The steamed and dried rhizome of G. elata, known as "Tianma" in Chinese, is used for the treatment of neuralgic and nervous disorders, such as headaches, migraine, dizziness, tetanus, epilepsy, neuralgia and paralysis. It is also considered to have health benefits enhancing strength and virility and improving memory and blood circulation 2 . Chemical and pharmacological studies indicated that 4-hydroxybenzyl analogs and 4-hydroxybenzyl-substituted metabolites were main active constituents of ethanol or methanol extracts of this medicine [3] [4] [5] [6] [7] [8] . As part of a program to assess the chemical and biological diversity of traditional Chinese medicines [9] [10] [11] [12] [13] [14] [15] [16] , a detailed chemical study was conducted on the aqueous extract of G. elata rhizomes, together with biological assays, since their decoctions are practically used in a variety of formulations. A fraction mainly contained parishin and parishins B and C (total content 450%), and at dosages of 10.00 À0.25 mg/kg, the purified parishins improved the impaired memory in mice caused by scopolamine or cycloheximide 17 . In addition, 23 known compounds were characterized from the extract 18 , and a minor component N 6 -(4-hydroxybenzyl)-adenosine (NHBA) 19 was isolated as the key sedative and hypnotic constituent of the extract, exhibiting significant activity at a dosage of 0.2 mg/kg (i.p.) 20 . Therefore, we carried out further investigation on other minor components in the extract. This has resulted in isolation and characterization of seven new 4-hydroxybenzyl-substituted amino acid derivatives 1 À 7 ( Fig. 1) , along with 11 known compounds. Reported herein are the isolation, structure determination, and biological activity of these isolates.
Results and discussion
Compound 1 showed IR absorptions due to hydroxyl (3216 cm NO 4 236.0917) and the NMR spectral data ( Table 1 ). The NMR spectral data of 1 showed that this compound consisted of 4 0 -hydroxybenzyl and pyroglutamate moieties 21 . This was verified by the 1 H-1 H COSY correlations of H-2/H 2 -3/H 2 -4 and HMBC correlations from H-2 to C-1, from H 2 -3 to C-1 and C-5, and from H 2 -4 to C-5. In particular, the HMBC correlations from H 2 -7 0 to C-2 and C-5 located the 4 0 -hydroxybenzyl unit at the N atom of the pyroglutamate moiety. Thus, the planar structure of 1 was determined as N-(4 0 -hydroxybenzyl)pyroglutamate. The absolute configuration of 1 was assigned by synthesis of enantiomers (þ)-(S)-and (
pyroglutamates, starting with L-and D-glutamic acids, respectively. The CD and specific rotation data of 1 were consistent with those of (þ)-(S)-[N-(4 0 -hydroxybenzyl)] pyroglutamate. Therefore, the structure of compound 1 was determined as shown.
Compound 2 has the molecular formula C 14 H 17 NO 4 as indicated by the HR-ESI-MS and NMR data (Table 1 and Section 4). Comparison of the NMR data of 2 and 1 indicated the presence of an ethoxy group [δ H 4.11 (q, 2H, J ¼7.2 Hz) and δ H 1.21 (t, 3H, J ¼ 7.2 Hz); δ C 61.7 and δ C 14.4] and shielded shifts of C-1 and C-5 by Δδ C À0.7 ppm and À0.6 ppm, respectively in 2. This revealed that 2 is the ethyl ester of 1, which was confirmed by the HMBC correlation from OCH 2 CH 3 to C-1 in the HMBC spectrum of 2. The CD and specific rotation data of 2 were similar with those of 1, indicating that the two compounds have the same configuration, which was further confirmed by synthesis of the enantiomers, ethyl
pyroglutamates. The CD and specific rotation data of 2 were in agreement with those of the former enantiomer. Thus, the structure of compound 2 was determined as shown.
The molecular formula C 21 H 23 NO 5 of compound 3 was determined from its HR-ESI-MS and NMR data (Table 1 and Section 4). Comparison of the NMR data of 3 and 2 suggests that 3 is an analog of 2 with an additional 4″-hydroxybenzyl unit substituted at C-3 0 . This was confirmed by the 1 H-1 H COSY correlations of H-2/H 2 -3/H 2 -4 and HMBC correlations of H-2/C-1 and C-5; H 2 -3/C-1 and C-5; H 2 -4/C-5; OCH 2 CH 3 /C-1; 4 00 -OH/ C-3 00 , C-4 00 , and C-5 00 ; H-7 00 /C-2 0 , C-3 0 , C-4 0 , C-1 00 , C-2 00 , and C-6 00 ; 4 0 -OH/C-3 0 , C-4 0 , and C-5 0 ; H-7 0 /C-1 0 , C-2, C-2 0 , C-5, and C-6 0 . Similarity of the CD and specific rotation data between 3 and 2 suggested the same 2(S) configuration for the two compounds. Thus, compound 3 was determined as
Figure 1
The structures of compounds 1À 8.
Substituted amino acid derivatives from Gastrodia elata
Compound 4 has the molecular formula C 11 H 14 O 4 S as indicated by the HR-ESI-MS and NMR data ( Table 1 6 demonstrated the replacement of the amino group in the synthetic compound by a hydroxyl group in 4. This was proved by the twoand three-bond correlations from H 2 -3 to C-7 0 ; from H 2 -7 0 to C-1 0 , C-2 0 (C-6 0 ), and C-3; from OH to C-1, C-2, and C-3; and from OCH 3 to C-1 in the HMBC spectrum of 4. The absolute configuration at C-2 in 4 was determined by the modified Mosher's method 0 of the benzyl unit is away from the chiral center (C-2) in the bis-MPA esters, the chemical shift change of protons around C-2 is mainly induced by the MPA moiety at C-2. From the MPA determination rule based on the Δδ RS values (Fig. 2) , the configuration of 4 was assigned as 2S. Therefore, the structure of compound 4 was determined as shown. (Fig. 2) . Thus, compound 5 was determined as ethyl (þ)-(S)-2-hydroxy-3-
The spectroscopic data of compound 6 indicated that it is the acid form of 4 and 5. The NMR data of 6 demonstrated a deshielded shift of the C-1 resonance (Δδ C 4þ3.0 ppm), as compared with that of 4 or 5, in addition to the absence of the methoxyl or ethoxyl group. An ethanol solution of 6 was treated with thionyl chloride (SOCl 2 ) to yield 5. Therefore, compound 6
The spectroscopic data of compound 7 indicated that it is an isomer of 5. Comparing the NMR data of these two compounds and from H 2 -7 0 to C-4 verified the 4 0 -hydroxylbenzyl unit located at the sulfur atom. The 2R configuration of 7 was determined by using the same protocol as described for 4 and 5 (Fig. 2) . Therefore, compound 7 was determined as methyl (
The acid/ester pair of 1/2 and the ethyl ester 3 are considered as natural products because HPLC-ESI-MS analysis using the ion extraction method demonstrated their occurrence in the crude extract or an CH 3 CN-eluted fraction without contacting with EtOH. In addition, methylation or ethylation of the acids and hydrolysis of the esters were unlikely to occur in the isolation procedure because refluxing the EtOH solution of L-[N-(4 0 -hydroxybenzyl)]glutamic acid only produced 1, whereas 2 was obtained by subsequent addition of thionyl chloride (SOCl 2 ) in the solution. However, the esters 4, 5, and/or 7 may be artifacts because 6 was esterified by keeping the MeOH solution at room temperature for a month, producing the ester with the spectroscopic features identical to that of 4 (Figs. S125-127 in Supporting information).
The known compounds were identified by comparing their spectroscopic data with the reported data as cyclo[glycine-L-S-(4 00 -hydroxybenzyl)cysteine] In the in vitro bioassays, compound 8 showed activity against Fe 2þ -cysteine induced rat liver microsomal lipid peroxidation, with IC 50 value of 9.99 Â 10 À 6 mol/L (the positive control, glutathione, gave IC 50 20.21 Â 10 À 6 mol/L). All other compounds isolated in this experiment were inactive at the same concentration. In addition, these compounds were also evaluated for the scavenging activity of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and their inhibitory activity against Fe 2þ /cysteine-induced liver microsomal lipid peroxidation, several human cancer cell lines, HIV-1 replication, and all of them were inactive at a concentration of 10 À 5 mol/L.
Conclusion
Seven new 4-hydroxybenzyl-substituted amino acid derivatives (1À7), together with 11 known compounds, were isolated from an aqueous extract of the rhizomes of G. elata. Blume. Compounds 1À3 are pyroglutamate derivatives containing 4-hydroxybenzyl units at the N atom and 4À7 are the first examples of natural products with the 4-hydroxybenzyl unit linked via a thioether bond to 2-hydroxy-3-mercaptopropanoic acid (4À6) and 2-hydroxy-4-mercaptobutanoic acid (7), which would be biogenetically derived from cysteine and homocysteine, respectively. The enantiomers of compounds 1 and 2 were synthesized, and the absolute configurations of 4, 5 and 7 were assigned using Mosher's method. These results, combined with our previous studies 18 , provide an important clue for further studies of chemical transformation, structural modification, and biosynthesis of the diverse 4-hydroxybenzyl-substituted amino acid derivatives from the rhizome of G. elata, as well as for evaluations on other pharmacological models though the new compounds were inactive in the assays carried out in this study.
Experimental

General experimental procedures
Optical rotations were measured using a Rudolph Research Autopol III polarimeter. UV spectra were measured on a Cary 300 spectrometer. CD spectra were measured on a JASCO J-810 spectropolarimeter. IR spectra were recorded on a Nicolet 5700 FT-IR microscope spectrometer (FT-IR microscope transmission) by microscope transmission method. 1D-and 2D-NMR spectra were obtained on INOVA 400 MHz, 500 MHz, or SYS 600 MHz spectrometers (Varian), with solvent peaks serving as references (unless otherwise noted). ESI-MS data were measured with a Q-Trap LC/MS/MS (Turbo Ionspray source) spectrometer. HR-ESI-MS data were, in turn, measured on an AccuTOF-CS JMS-T100CS spectrometer (JEOL), and HR-EI-MS data were measured using a Micromass Autospec-Ultima ETOF spectrometer. Column chromatography was performed with silica gel (200-300 mesh, Qingdao Marine Chemical Inc., Qingdao, China) and Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden), Toyopearl HW-40C and HW-40F (Tosoh Bioscience LLC, Tokyo, Japan), and MCI gel (CHP20P) (Mitsubishi Chemical Inc., Tokyo, Japan). HPLC separation was performed on an instrument with a Waters 600 controller, a Waters 600 pump, and a Waters 2487 dual λ absorbance detector (detecting wavelength: 230 nm) on a Grace (250 mm Â 10 mm, i.d.) semi-preparative column packed with C18 (5 μm), and an YMC-Pack (250 mm Â 10 mm, i.d.) column packed with Ph (5 μm). Glass precoated silica gel GF254 plates were used for TLC. Spots were visualized under UV light or by spraying with 5% H 2 SO 4 in EtOH, followed by heating.
Plant material
The rhizomes of G. elata were collected at the plantation field of Xiaocao Ba, Yunnan province, China, in December 2009. 
Extraction and isolation
The steamed and air-dried G. elata rhizomes (50 kg) were pulverized and ultrasonicated with H 2 O (150 L Â 3 Â 1 h). The aqueous extracts were combined and evaporated under reduced pressure to yield a concentrated solution (50 L), which was loaded on a macroporous adsorbent resin (HPD-100, 30 kg) column Fraction C3 (237 g) was subjected to column chromatography (CC) over silica gel, eluting with a gradient of increasing MeOH concentration (0 À100%) in EtOAc followed by 30% EtOH, to yield fractions C3-1-C3-5 based on TLC analysis. Fraction C3-1 (27. ν max 3216, 3020, 2952, 2719, 1735 
Synthesis of 1 and 2
To a solution of L-or D-glutamic acid (2 g) in MeOH (30 mL), 4-hydroxybenzaldehyde (3 g) and anhydrous Na 2 CO 3 (3 g) were added. The mixture was stirred at r.t. 
Synthesis of methyl S-(4-hydroxybenzyl)-L-cysteinate
Methyl L-cysteinate (10 mg) and 4-hydroxybenzylalcohol (13 mg) were added to 5 mL of 2 mol/L HCl. The mixture was stirred at r.t. for 20 min, and extracted with EtOAc (5 Â 3 mL). 
